MentionFox
Home › funding signals › EndoSure, Inc.
Form D · on the record

EndoSure — $1.31M Form D filing, November 2026

Before you sell to, join or invest in EndoSure, Inc.

MentionFox check on EndoSure, Inc.: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/endosure-inc-form-d-000002

Check EndoSure, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about EndoSure, Inc.?

EndoSure, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-19.

EndoSure, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. The filing reports $1.31M sold. Its industry group is Other Health Care. It names Mark Noar (Corporate Secretary, Director), Mark November (Director), Carlos Babini (CEO, Director) (SEC Form D, November 19, 2026).

Sell to companies like EndoSure, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

EndoSure, Inc. raised on Nov 19. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Other Health Care raises in Maryland within 90 days ↓

Selling to EndoSure, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on EndoSure, Inc. →

EndoSure, Inc.

New Form D on file · 2026-11-19 · the record

$1.31M
raise on the record
D
filing
10
investors in
MARYLAND
based
Open the record →

What the record says

FilingForm D
Filed2026-11-19
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
Year formed2022
BasedSPARKS GLENCOE, MARYLAND
CIK2042877
Accession0002042877-26-000002

Pitching, partnering or investing alongside them? See who really runs and owns EndoSure, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind EndoSure, Inc., from the filings we hold.

More raises like this

Other Health Care raises by companies based in Maryland, filed within 90 days of this one, largest first.

What do you want to do with EndoSure, Inc.?

Get the full cited report on EndoSure, Inc.

What the filing shows about EndoSure, Inc.

  • 10 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on EndoSure, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look EndoSure, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on EndoSure, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives EndoSure, Inc.'s address as 954 Ridgebrook Road, Suite 220, Sparks Glencoe, MD 21152.

What the filing says

  • Offered: $1,655,404. Sold: $1,310,823. Left to sell: $344,581. (filing)
  • Investors: 10 had already invested. (filing)
  • Date of first sale: November 3, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on EndoSure, Inc. See pricing

Is EndoSure, Inc. a real, registered company?

EndoSure, Inc. is a registered filer with the SEC (CIK 2042877) and has filed since 2025-02-20. 2 filings are on record, the latest on 2026-11-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs EndoSure, Inc.?

EndoSure, Inc.'s Form D of 2026-11-19 names Mark Noar, Mark November and Carlos Babini as its officers, directors or promoters.

How much has EndoSure, Inc. raised?

Its new offerings report $1.46M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2025-02-20 · $150KForm D · 2026-11-19 · $1.31M · this page 2025-02-20 2026-11-19

Each marker is one filing. The larger marker is the filing this page is about.

Other Health Care · by week
This raise, $1.31M, filed week of Nov 16

Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $1.31M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on EndoSure, Inc.?

What the filing shows about EndoSure, Inc.

  • 10 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on EndoSure, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on EndoSure, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for EndoSure, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

EndoSure, Inc.: Raised $1.31M, Form D filed 2026-11-19
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/endosure-inc-form-d-000002
Last updated 2026-11-20
Primary record: SEC filing 1 · SEC filing 2
EndoSure raised $1.31M — SEC Form D filing, November 2026. MentionFox, 2026-11-20. https://mentionfox.com/funding/endosure-inc-form-d-000002